Predictive Oncology Inc (POAI)

[77Port]

I owned shares prior to the 10/1 RS and now I have fewer shares. That's fine. That's the world of buying speculative medical companies. But over the years, this company has given endless promises. That they haven't died is somewhat impressive. Will this time be different?

If this is different, POAI will get it's due. Today's news does, on the surface, seem good. But today's news is still just a press release about a future possibility. When they begin writing less about what might happen, as in "achieved a key milestone toward monetizing," ... will bring us closer," and write about how much monetization has happened in real numbers, then the stock will pop. This company has used up all of the fluffy words available to them. Now they need real results or nothing.

March 24 2022 - 08:30AM GlobeNewswire Inc.

Predictive Oncology (NASDAQ: POAI) achieved a key milestone toward monetizing its unique approach to leverage artificial intelligence (AI) in oncology drug discovery. Earlier this year, Predictive Oncology’s Discovery 21 proof-of-concept campaign demonstrated the ability of its Patient-centric Discovery by Active Learning (PeDAL) platform to make high-confidence predictions of drug response on ovarian tumors samples. The results from Discovery 21 are now validated: PeDAL accurately and reproducibly predicted drug response results.
“These results demonstrate that PeDAL works with real world drug compounds and tumor samples,” J. Melville (Mel) Engle, Predictive Oncology’s Chairman and Chief Executive Officer. “We expect that pharma will be keen to use this technology, which increases the probability of technical success and lowers both the cost and time of bringing new drugs to market. This in turn will bring us closer to our overall mission of determining optimal therapies for the treatment of cancer.”

If there is genuine follow through to these promising words, I will be glad I held on. I'll believe it when I see it.

https://ih.advfn.com/stock-market/NASDAQ/predictive-oncology-POAI/stock-news/87644443/predictive-oncology-validates-discovery-21-proof-o